The momentum behind psychedelic policy reform has surged over the past five years—especially within state legislatures. With over 220 bills introduced across 38 states and D.C. since 2020, the field is evolving rapidly. But sustained progress requires a clearer understanding of what’s working—and what’s not.
Sam Chapman
Psychedelic-assisted therapy training programs are expanding, but the role of the psychedelic guide is still evolving. This presentation explores the qualities and influences shaping the modern psychedelic guide.
Valeria McCarroll
Speaker discusses underlying assumptions of psychedelic therapy and therapist's role, emphasizing presence in facilitating healing. Draws from personal experiences with MDMA, psilocybin, and ketamine research volunteers.
Norma Stevens
Visionaries in Colorado and Oregon are shaping new psychedelic eco-systems by teaching, educating, and building businesses and nonprofits. Dreams are becoming reality in these emerging landscapes.
Jamie Beachy, Steve Elfrink, Martha Hammel, Nate Howard, Meaghan Len Richmond, Barine Majewska
Leaders of Oregon and Colorado campaigns discuss the historic creation of state frameworks for psychedelic healing, detailing the journey, current status, and future directions. Total words: 26
Kevin Matthews, Joshua Kappel
Psychedelic retreat centers are operating worldwide, with Oregon and Colorado preparing to regulate similar centers. These venues offer access to psychedelic experiences outside clinical settings, raising questions about their differences
Alexandra Pallas, Melissa Stangl, Ann “Annie Oak” Harrison
Panel on regulatory obstacles in psychedelic therapy research: Leaders from the industry discuss challenges with policymakers and predict future developments in the field.
Tadeusz Hawrot, Natasia Poinsatte, Nicole Howell
Dr. Smith and Dr. Jones analyze the economic impact of drug pricing and care costs on the psychedelic market at PS2023.
Panel: New psychedelic entrepreneurs discuss unique business structures and financial strategies aligning with values and purpose, rejecting traditional models for innovative, purpose-driven for-profit ventures.
Daniel Tarockoff, Scarlet Masius
Universities and companies are claiming intellectual property on psychedelic compounds, sparking dialogue on how patents may impact innovation and access to care in the psychedelic ecosystem. Explore economic and cultural
Jonathan Sporn, Sisi Li, Graham Pechenik, Retsina Meyer, Anne Donohoe
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.